A detailed history of Chartwell Investment Partners, LLC transactions in Insmed Inc stock. As of the latest transaction made, Chartwell Investment Partners, LLC holds 15,069 shares of INSM stock, worth $1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
15,069
Previous 14,947 0.82%
Holding current value
$1 Million
Previous $1 Million 9.89%
% of portfolio
0.04%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$62.0 - $79.01 $7,564 - $9,639
122 Added 0.82%
15,069 $1.1 Million
Q2 2024

Aug 08, 2024

SELL
$22.0 - $69.71 $318,318 - $1.01 Million
-14,469 Reduced 49.19%
14,947 $1 Million
Q1 2024

May 14, 2024

BUY
$25.72 - $29.94 $139,325 - $162,184
5,417 Added 22.57%
29,416 $798,000
Q4 2023

Feb 15, 2024

BUY
$23.42 - $31.74 $242,115 - $328,128
10,338 Added 75.68%
23,999 $744,000
Q2 2023

Jul 25, 2023

BUY
$16.44 - $21.1 $10,916 - $14,010
664 Added 5.11%
13,661 $288,000
Q1 2023

Apr 14, 2023

SELL
$16.26 - $21.73 $142,632 - $190,615
-8,772 Reduced 40.3%
12,997 $221,000
Q4 2022

Feb 15, 2023

BUY
$16.98 - $23.15 $21,055 - $28,706
1,240 Added 6.04%
21,769 $435,000
Q3 2022

Oct 27, 2022

BUY
$20.88 - $28.21 $428,645 - $579,123
20,529 New
20,529 $442,000
Q4 2018

Feb 01, 2019

SELL
$11.6 - $18.7 $398,703 - $642,737
-34,371 Closed
0 $0
Q3 2018

Nov 08, 2018

SELL
$18.95 - $28.08 $1 Million - $1.49 Million
-52,927 Reduced 60.63%
34,371 $695,000
Q2 2018

Aug 09, 2018

SELL
$20.0 - $29.72 $357,300 - $530,947
-17,865 Reduced 16.99%
87,298 $2.07 Million
Q1 2018

May 08, 2018

BUY
$21.69 - $32.99 $1.14 Million - $1.73 Million
52,535 Added 99.82%
105,163 $3.28 Million
Q1 2018

May 08, 2018

SELL
$21.69 - $32.99 $1.14 Million - $1.73 Million
-52,535 Reduced 49.96%
52,628 $1.19 Million
Q4 2017

Feb 08, 2018

SELL
$26.43 - $31.78 $186,648 - $224,430
-7,062 Reduced 6.29%
105,163 $3.28 Million
Q3 2017

Nov 08, 2017

BUY
$11.61 - $31.21 $1.3 Million - $3.5 Million
112,225
112,225 $3.5 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.02B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.